Hypersecretion
Showing 1 - 25 of 719
Acute Respiratory Failure, Acute-on-chronic Respiratory Failure, Airway Clearance Impairment Trial in Arezzo (High Frequency
Recruiting
- Acute Respiratory Failure
- +2 more
- High Frequency Chest Wall Oscillations via The Vest® Airway Clearance System
-
Arezzo, AR, ItalyOspedale San Donato
Feb 25, 2023
Development of "T-sec" Questionnaire
Not yet recruiting
- Asthma
- Questionnaire
- (no location specified)
Sep 20, 2022
Type 2 Diabetes, Obesity and Cortisol Excess
Recruiting
- Diabetes Mellitus, Type 2
- +2 more
- 1mg DST
-
Milan, ItalyIstituto Auxologico Italiano
Mar 9, 2023
Long-Term Follow-Up of Survivors of Pediatric Cushing Disease
Recruiting
- Cushing Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Pituitary ACTH Hypersecretion, Acromegaly, Diabetes, Type 1 Trial in Moscow (Cholecalciferol 15000 UNT/ML Oral Solution)
Completed
- Pituitary ACTH Hypersecretion
- +3 more
- Cholecalciferol 15000 UNT/ML Oral Solution
-
Moscow, Russian FederationEndocrinology Research Centre, Moscow
Aug 10, 2022
Effect of Maternal Cortisol Levels on Fetal Heart Rate Patterns
Not yet recruiting
- Stress
- +2 more
- (no location specified)
Aug 15, 2022
Polycystic Ovary Syndrome, Obesity, Androgen; Hypersecretion Trial in Ankara (intervention diet, control diet)
Completed
- Polycystic Ovary Syndrome
- +3 more
- intervention diet
- control diet
-
Ankara, TurkeyEsra Döğer
Mar 3, 2023
Cushing's Disease Trial run by the NINDS (Vorinostat)
Recruiting
- Cushing's Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Pituitary Tumors and Related Hypothalmic Disorders
Recruiting
- Panhypopituitarism
- +3 more
- MRI
- Tissue specimen collection
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Cushing's Disease, Pituitary Adenoma Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Acthrel)
Not yet recruiting
- Cushing's Disease
- Pituitary Adenoma
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Cushing Syndrome, Cushing Disease, Ectopic ACTH Syndrome Trial run by the Crinetics Pharmaceuticals Inc. (CRN04894)
Recruiting
- Cushing Syndrome
- +2 more
-
Bethesda, MarylandNational Institutes of Health (NIH) - National Institute of Diab
Mar 27, 2023
Cushing Disease Trial in Los Angeles (Seliciclib)
Active, not recruiting
- Cushing Disease
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
May 24, 2022
Polycystic Ovary Syndrome, Insulin Resistance, Androgen; Hypersecretion Trial in Dublin 9 (Dehydroepiandrosterone (DHEA),
Recruiting
- Polycystic Ovary Syndrome
- +3 more
- Dehydroepiandrosterone (DHEA)
- 11-ketoandrostenedione (11KA4)
-
Dublin 9, IrelandBeaumont Hospital
Apr 26, 2022
Cushing Disease, DVT, Pulmonary Embolism Trial in China (LMWH/Rivaroxaban, IPC)
Recruiting
- Cushing Disease
- +2 more
- LMWH/Rivaroxaban
- IPC
-
Guangzhou, Guangdong, China
- +3 more
Jul 10, 2022
Gastro Esophageal Reflux Disease, Dyspepsia, Rebound Acid Hypersecretion Trial (Spirulina platensis, Placebo comparator)
Completed
- Gastro Esophageal Reflux Disease
- +2 more
- Spirulina platensis
- Placebo comparator
- (no location specified)
Jul 30, 2021
Stress, Emotional, Dental Anxiety, Dental Pain and Sensation Disorder Trial in Poznan (GROUP)
Recruiting
- Stress, Emotional
- +3 more
- GROUP
-
Poznań, PolandPoznan University of Medical Sciences
Aug 19, 2021
Discriminant Capacity and Thresholds of Salivary Cortisol in
Recruiting
- Cushing Disease
- Blood test
- +3 more
-
Nîmes, FranceCHU de Nimes
Oct 4, 2021
Patients With Cushing's Syndrome
Recruiting
- Cushing's Disease
- +2 more
- Cushing's QoL (Quality of Life Questionnaire)
- +10 more
-
Basking Ridge, New Jersey
- +6 more
Jan 13, 2023
Cushings Disease Trial in Los Angeles (R-roscovitine)
Terminated
- Cushings Disease
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Nov 1, 2021
Novel Mediators of Lipodystrophy and Metabolic Consequences of
Completed
- Cushing's Syndrome
- Treatment of Cushing's
-
New York, New YorkColumbia University Neuroendocrine Unit
Jul 12, 2021
Cushing Disease Trial in France (Patient group, Remission control group, Bilateral surrenalectomy control group)
Recruiting
- Cushing Disease
- Patient group
- +2 more
-
Caen, France
- +6 more
Dec 16, 2021
Iatrogenic Cushing's Disease Trial in Oxford (AZD4017 and prednisolone, Placebo Oral Tablet and prednisolone)
Completed
- Iatrogenic Cushing's Disease
- AZD4017 and prednisolone
- Placebo Oral Tablet and prednisolone
-
Oxford, United KingdomUniversity of Oxford
May 12, 2021